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Development of the Schwann cell lineage: from the neural crest
to the myelinated nerve
Abstract
The myelinating and nonmyelinating Schwann cells in peripheral nerves are derived from the neural
crest, which is a transient and multipotent embryonic structure that also generates the other main glial
subtypes of the peripheral nervous system (PNS). Schwann cell development occurs through a series of
transitional embryonic and postnatal phases, which are tightly regulated by a number of signals. During
the early embryonic phases, neural crest cells are specified to give rise to Schwann cell precursors,
which represent the first transitional stage in the Schwann cell lineage, and these then generate the
immature Schwann cells. At birth, the immature Schwann cells differentiate into either the myelinating
or nonmyelinating Schwann cells that populate the mature nerve trunks. In this review, we will discuss
the biology of the transitional stages in embryonic and early postnatal Schwann cell development,
including the phenotypic differences between them and the recently identified signaling pathways,
which control their differentiation and maintenance. In addition, the role and importance of the
microenvironment in which glial differentiation takes place will be discussed. 
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ABSTRACT 
The myelinating and non-myelinating Schwann cells in peripheral nerves are derived 
from the neural crest, which is a transient and multipotent embryonic structure that 
also generates the other main glial sub-types of the peripheral nervous system (PNS). 
Schwann cell development occurs through a series of transitional embryonic and 
postnatal phases, which are tightly regulated by a number of signals. During the early 
embryonic phases, neural crest cells are specified to give rise to Schwann cell 
precursors, which represent the first transitional stage in the Schwann cell lineage, 
and these then generate the immature Schwann cells. At birth, the immature Schwann 
cells differentiate into either the myelinating or non-myelinating Schwann cells that 
populate the mature nerve trunks. In this review, we will discuss the biology of the 
transitional stages in embryonic and early postnatal Schwann cell development, 
including the phenotypic differences between them and the recently identified 
signalling pathways, which control their differentiation and maintenance. In addition, 
the role and importance of the microenvironment in which glial differentiation takes 
place will be discussed. 
 
The Schwann cell precursor – an intermediate stage during PNS gliogenesis 
 Glia cells in the peripheral nervous system (PNS), including satellite cells in 
peripheral ganglia, and myelinating and non-myelinating Schwann cells in nerve 
trunks, are derived from neural crest cells. During vertebrate development, neural 
crest cells emerge at the dorsalmost part of the neural tube, from where they 
delaminate and extensively migrate to various locations within the embryo (reviewed 
in Le Douarin and Dupin, 2003). Dependent on the local environment, neural crest 
cells become gradually fate restricted to generate neural cells of the sensory, 
autonomic, and enteric nervous system as well as several non-neural cell types, such 
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as smooth muscle cells in the outflow tract of the heart, pigmented melanocytes in the 
skin, and craniofacial bones, cartilage, and connective tissue. At least some neural 
crest cells are multipotent, as shown by clonal analysis in culture and in vivo 
(reviewed in Le Douarin and Dupin, 2003 and Sommer, 2001). Moreover, serial 
subcloning revealed that some neural crest cells have features of stem cells with the 
capacity to self-renew (Stemple and Anderson, 1992). Intriguingly, such neural crest-
derived stem cells (NCSCs) can be isolated from various neural crest target structures, 
in addition to the migratory neural crest (Bixby et al., 2002; Fernandes et al., 2004; 
Sieber-Blum et al., 2004; Trentin et al, 2004; reviewed in Delfino-Machin et al., 
2007). In particular, NCSCs can be found at sites of gliogenesis, including the sciatic 
nerve and dorsal root ganglia (DRG) (Morrison et al., 1999; Hagedorn et al., 1999). 
Multipotency and self-renewal capacity are also displayed by cells expressing early 
glial markers such as P0, PMP22, and Desert Hedgehog (Dhh). This phenomenon is 
seen perhaps most strikingly in radial glial cells in the CNS, which also exhibit 
multipotency (reviewed in Pinto and Gotz, 2007). Dhh is expressed in the peripheral 
glial lineage from early stages onwards, but not in the migratory neural crest (Jaegle 
et al., 2003). Strikingly, even in the adult trunk skin, cells genetically marked by Dhh 
expression have been shown to exhibit NCSC features, and to be able to self-renew 
and generate various cell types typical for the neural crest (Wong et al., 2006). 
Although the physiological role of these adult NCSCs remains to be elucidated, they 
are conceivably involved in repair and regeneration of neural crest-derived structures 
in the injured skin. Furthermore, the presence of such cells in the adult organism 
raises the possibility that PNS tumors originate from NCSC-like cells. 
Despite the persistence of NCSCs associated with the glial lineage during 
development and into adulthood, glial specification and differentiation occurs already 
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at early stages of embryonic development. In spinal nerves, Schwann cell generation 
is a protracted process that involves two embryonic transitional stages; first is the 
process of gliogenesis, whereby the neural crest cells are specified to form Schwann 
cell precursors (SCPs), followed by a maturation of these cells into immature 
Schwann cells (Dong et al., 1995, 1999; Jessen et al., 1994). These cells then 
differentiate to form mature myelinating and non-myelinating Schwann cells. In the 
rat, SCPs are present in the spinal nerves at around embryonic day 14/15 (E14/15) and 
they give rise to immature Schwann cells, which are present in the nerves at around 
E17/18 (Jessen et al., 1994). In the mouse, however, this stage of Schwann cell 
development proceeds two days earlier; SCPs are present in the nerves at around 
E12/13, and they give rise to Schwann cells, present at around E15/16 (Dong et al., 
1999).  
SCPs are unambiguously distinct from their immediate progenitors, NCSCs, 
and their progenies, the immature Schwann cells, in a range of phenotypic features, 
including molecular markers and survival responsiveness to growth factors (Figure 1). 
For instance, SCPs can be distinguished from NCSCs by in vivo expression of 
BFABP, P0 and Cadherin-19, amongst others (reviewed in Jessen and Mirsky, 2005). 
In addition, the survival requirements of these two cell-types differ significantly, 
when analysed in vitro. SCPs, unlike NCSCs, do not require extracellular matrix for 
neuregulin-1 (NRG1)-dependent survival. Similarly, growth factor combinations, 
including fibroblast growth factor (FGF) plus insulin-like growth factor (IGF), 
platelet-derived growth factor (PDGF) plus neurotrophin 3 (NT3) and IGF, and 
endothelin plus IGF, promote the survival of SCPs, but not of NCSCs under identical 
conditions (Woodhoo et al., 2004).  
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Transgenic mice expressing green fluorescent protein (GFP) from a promoter 
active in both migratory neural crest cells and the glial lineage allowed the isolation 
of homogeneous populations of NCSCs and of cells representing various stages of SC 
development (Buchstaller et al., 2004). Global gene expression analyses of these 
populations revealed a surprisingly large group of genes differentially expressed in 
NCSCs and SCPs, among which were many genes encoding novel receptor protein 
kinases and phosphatases. These findings suggest that a complex genetic program is 
involved in either promoting glial specification, suppressing stem cell maintenance, or 
inhibiting neurogenesis in neural crest cells adopting a glial fate. 
Although less frequent than the changes observed between migratory NCSCs 
and SCPs, substantial differences were also revealed by gene expression profiling of 
glial cells present in peripheral nerves at different stages (Buchstaller et al., 2004). 
Indeed, SCPs are antigenically very different from immature Schwann cells. 
Differentiation of SCPs to immature Schwann cells results in upregulation of markers 
such as GFAP and S100β, as well as downregulation of markers, including N-
cadherin, Cadherin-19 and AP2α (reviewed in Jessen and Mirsky, 2005). Moreover, 
survival mechanisms differ strikingly between SCPs and Schwann cells when 
analysed in vitro. Schwann cells can support their own survival, when plated at high 
densities, by secreting factors including IGF-2, NT-3, PDGF-β , leukaemia inhibitory 
factor (LIF), and lysophosphatidic acid into the culture medium, whereas SCPs do not 
possess such autocrine survival circuits (Dowsing et al., 1999; Meier et al., 1999, 
Weiner and Chung, 1999).  
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Glial specification of neural crest cells 
It is still unclear how exactly SCPs are specified from NCSCs. Transcription 
factors actively promoting peripheral gliogenesis, comparable to proneural factors 
inducing neurogenesis (reviewed in Bertrand et al., 2002), have so far not been 
identified in vertebrates. It has therefore been proposed that gliogenesis might be 
enabled by default when neurogenesis or other alternative fates are suppressed 
(reviewed in Jessen and Mirsky 2005). The transcription factor Sox10 is persistently 
expressed in glia of peripheral ganglia and nerves as well as differentiating 
melanocytes, while it is absent in neurons and other non-neural derivatives of the 
neural crest (Kuhlbrodt et al., 1998; reviewed in Wegner, 2005). Consistent with this 
expression pattern, Sox10-mutant mice lack peripheral glia (Britsch et al., 2001) and, 
even when challenged with gliogenic cues, Sox10-deficient NCSCs are unable to 
acquire a glial fate (Paratore et al., 2001). However, Sox10 is not confined to the glial 
lineage but is expressed in virtually all migratory and postmigratory NCSCs, 
indicating that Sox10 alone is not sufficient for glial fate determination. Rather, Sox10 
regulates multipotency and glial fate decision of NCSCs in a context-dependent 
manner by altering their responsiveness to extracellular cues (Paratore et al., 2001; 
Kim et al, 2003). 
Sox10 might affect, for instance, the response of neural crest cells to the 
extracellular factor NRG1 by regulating expression of the NRG receptor ErbB3 
(Britsch et al., 2001). In clonal cultures of NCSCs, NRG1 instructively promotes 
gliogenesis at the expense of other possible fates (Shah et al., 1994). Simultaneous 
exposure of NCSCs to NRG1 and low doses of neurogenic growth factors revealed 
that NRG1 might exert its effect on gliogenesis by an inhibitory influence on 
neurogenesis, although a positive role of NRG1 on gliogenesis cannot be excluded by 
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these data (Shah and Anderson, 1997). Mice mutant for NRG1 signalling components 
exhibit drastically reduced numbers of SCPs along peripheral nerves, while satellite 
glia appear not to be affected (Garratt et al., 2000a). The presence of satellite glia in 
mutant mice led to the conclusion that NRG1 signalling is not required for glial fate 
acquisition.  
Alternative explanations for these results are, however, possible. First, in 
mutant embryos, lack of NRG1 signalling might be compensated by other gliogenic 
signals in ganglia but not peripheral nerves. A candidate for such a compensatory 
factor is signalling by Notch that, similar to NRG1, can instruct NCSCs to adopt a 
glial fate, even upon transient signal activation (Morrison et al., 2000; Kubu et al., 
2002). Based on these data it has been proposed that Notch signalling might act as an 
irreversible switch to promote gliogenesis in NCSCs. Interestingly, however, ablation 
of the Notch signalling effector Rbp/j in NCSCs perturbs gliogenesis only in 
peripheral ganglia, while Schwann cell generation along peripheral nerves is not 
affected (Taylor et al., 2007). Furthermore, undifferentiated NCSCs persist in the 
mutant, indicating that Notch does not control NCSC maintenance. Thus, 
physiological Notch signalling is apparently not involved in peripheral glial 
specification in general. Rather, Notch might play a role specifically in satellite 
gliogenesis in vitro and in vivo. As discussed for NRG1 signalling, this might be 
achieved primarily by Notch-mediated suppression of neurogenesis in peripheral 
ganglia. 
Apart from compensatory mechanisms, there is a second possible explanation 
for the differential effects of NRG1- and Notch signal inactivation on satellite glia vs. 
Schwann cells: these peripheral glia might represent distinct lineages with specific 
factor requirements for their development (Figure 2). In terms of survival, in vitro 
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studies show that developing satellite cells and SCPs have different requirements 
(Woodhoo et al., 2004). For example, IGF-1 promotes the survival of developing 
satellite cells but not of SCPs and there is also an earlier appearance of autocrine 
survival mechanisms in satellite cells. Other cell culture studies show other intrinsic 
differences between satellite cells and Schwann cells. Whereas satellite glia formation 
from NCSCs is promoted by a soluble form of NRG1, Schwann cell generation is 
triggered by its membrane-bound isoform (Leimeroth et al., 2002). In vivo, satellite 
glia can be distinguished from Schwann cells by expression of the Ets-domain 
transcription factor Erm from early stages onwards (Hagedorn et al., 2000). 
Intriguingly, soluble NRG1 can also upregulate Erm expression in glial progenitors 
derived from DRG but not from peripheral nerves, indicating intrinsic differences 
between DRG satellite glia and Schwann cell lineages. It remains to be shown 
whether Notch signal activation specifically promotes the generation of Erm-positive 
satellite glia as opposed to Erm-negative Schwann cells.  
In vivo cell fate mapping experiments support the hypothesis that distinct 
peripheral glial lineages segregate at an early developmental stage, presumably 
already at the time of emigration of neural crest cells from the neural tube (Zirlinger 
et al., 2002). Emigrating neural crest cells expressing the sensory marker neurogenin 
(Ngn)2 were shown to give rise predominantly to neurons and glia in the DRG, and 
glia in surrounding nerve roots, while autonomic neurons and glia, as well as the 
majority of SCPs in peripheral nerves, do apparently not originate from the Ngn2-
positive neural crest cell population. Satellite cells of different ganglia are also 
intrinsically different from one another. For example, sensory ganglia satellite cells 
express surface G1, G2 and GLI 1, unlike satellite cells from sympathetic ganglia 
(Rudel and Rohrer, 1992). In addition, cells present within sensory ganglia exhibit 
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developmental capabilities different from those of autonomic ganglia, as shown by in 
vivo quail-chick transplantation assays (Le Lievre et al., 1980). Thus, multipotent 
neural progenitors of the PNS are biased for a given neural subtype identity, such as 
sensory vs. autonomic, before commitment to neuronal or glial fates. Given this 
lineage bias observed already at early stages of neural crest development, it can 
presently not be excluded that peripheral glia are specified by distinct genetic 
programs, dependent on their association with sensory ganglia, autonomic ganglia, or 
peripheral nerves. Adding to the complexity are neural crest-derived boundary cap 
cells that are localized at the spinal cord surface at the nerve root entry and exit zones 
(Maro et al., 2004) (Figure 2). These cells give rise to all Schwann cells of the dorsal 
root and a subpopulation of ventral root Schwann cells and DRG satellite glia, as well 
as to nociceptive neurons. Given their particular origin, it is conceivable that 
boundary cap-derived glia are specified by cues distinct from the specification factors 
of other satellite glia and SCPs. 
 
Cytoarchitecture of developing peripheral nerves 
The newly formed embryonic nerves are a tightly packed structure with no 
extracellular matrix and no apparent connective tissue and blood vessels. SCPs are 
initially found at the edges of nerves as well as within the larger nerve trunks. They 
have extensive sheet-like processes connected to each other by adherens junctions and 
surround large groups of axons. They are also intricately associated with growth 
cones at nerve fronts (Jessen et al., 1994; Wanner et al., 2006b). During normal mice 
embryogenesis (E14 and onwards), the axons within peripheral nerves reach their 
target areas and establish the first synaptic connections (Altman and Bayer 1984; 
Jackman and Fitzgerald, 2000; Wolpowitz et al., 2000; Ziskind-Conhaim, 1988). This 
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period of time also coincides with the differentiation of SCPs into immature Schwann 
cells, with their associated phenotypic changes as well as a profound re-shaping of the 
general cytoarchitecture of the nerves. From a tightly packed structure with no 
extracellular space, the nerves start to elaborate an endoneurial space with abundant 
fibrous connective tissue containing blood vessels, endoneurial fibroblasts and ‘axon-
Schwann cell families’. The nerve also becomes progressively ensheathed by a 
developing layer of perineurial cells (Wanner et al., 2006b). These ‘axon-Schwann 
cell families’ essentially consist of axons grouped together in small bundles by 
Schwann cells surrounding them, and are similar to the ones described in postnatal 
nerves (Webster and Favilla, 1984). A recent study is consistent with the possibility 
that the compact nature of early developing nerves is maintained by extensive SCP-
SCP contact, mediated by the cell-adhesion molecule N-cadherin. As the SCPs 
differentiate into immature Schwann cells, N-cadherin is strongly downregulated in 
vivo and this coincides with the change in the cytoarchitecture of the nerves (Wanner 
et al., 2006a). In addition, Cadherin-19 is also strongly expressed in SCPs and is 
downregulated as they differentiate into immature Schwann cells (Takahashi and 
Osumi, 2005). It could potentially have a similar role to N-cadherin in compaction of 
early nerves. 
 
Axonal-glial interactions in developing nerves and their importance. 
The presence of SCPs is not required for the initial patterning of the 
developing nerves. In the Splotch mutant mice, which lack SCPs in the nerves, the 
initial guidance and outgrowth of axons to their target areas in the limbs occur 
normally (Grim et al., 1992). Rather, SCPs seem to be important for the late 
patterning events in the developing nerves. Genetic ablation of ErbB2 alleles also 
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results in a lack of SCPs in the developing nerves and the initial patterning events are 
normal. However, the nerves are poorly defasciculated and project aberrantly within 
their final target tissues. In addition, abnormal synaptic connections are formed at the 
neuromuscular junctions in the target areas (Morris et al., 1999; Woldeyesus et al., 
1999). These ErbB2 null mice also suggest an important function of SCPs in 
providing trophic support for developing neurons within the nerves. In these mutant 
mice, there is an initial generation of normal numbers of motor and sensory neurons, 
but after target innervation, there is widespread death of these neurons. Similarly, in 
other mutant mice, absence of SCPs, as a result of inactivation of the Sox10, ErbB3 or 
isoform III of NRG1 genes, contributes to severe degeneration of motor neurons and 
sensory neurons (Britsch et al., 2001; Riethmacher et al., 1997; Wolpowitz et al., 
2000).  
Survival of these two main cell types in the developing nerves is reciprocal. 
As much as neurons are dependent on SCPs for their survival, SCPs, themselves, 
require axon-derived factors for their survival, the most important identified, so far, 
being NRG1. Dissociated SCPs undergo apoptotic cell death, when cultured in the 
absence of axons, but they are able to survive, when cultured with axon-associated or 
secreted signals from DRG neurons. In both cases, the signal was identified as NRG1 
(Jessen et al., 1994; Dong et al., 1995, 1999). Similarly, pharmacological and surgical 
– induced death of axons contributes to apoptotic Schwann cell death, and exogenous 
NRG1 administration can rescue death induced by loss of axons (Ciutat et al., 1996; 
Winseck et al., 2002). Embryonic DRG axons and motor neurons express NRG1, 
which accumulates along axonal tracts (Falls et al., 1993; Loeb et al., 1999; 
Marchionni et al., 1993; Orr-Urtreger et al., 1993, Taveggia et al., 2005) and would 
therefore be available at the right time to regulate precursor survival. As mentioned 
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before, SCP numbers are severely reduced in mice, in which NRG1 signalling has 
been disrupted by genetic inactivation of either the NRG1 gene or its receptors ErbB2 
or ErbB3 (Garratt et al., 2000b; Meyer and Birchmeier, 1995; Morris et al., 1999; 
Riethmacher et al., 1997; Woldeyesus et al., 1999). Absence of SCPs in these mutant 
mice supports the idea of crucial role of NRG1 signalling in their survival. Further 
support is provided by the phenotype seen in the genetic disruption of 3 of the NRG1 
isoforms. Whereas mice lacking isoforms I and II show normal peripheral glia 
development, mice in which isoform III has been inactivated, show a severe depletion 
of SCPs and consequently Schwann cells in peripheral nerves (Meyer et al., 1997; 
Wolpowitz et al., 2000). 
NRG1 signalling is also important in directed cell migration of SCPs as shown 
by elegant studies in the zebrafish by Gilmour and colleagues (2002), and 
subsequently by Lyons and colleagues (2005) (reviewed in Lai, 2005). By analysing 
different zebrafish mutants, these researchers showed that axons provide guidance 
cues, in the form of ErbB signalling, for directed migration of SCPs. In rats also, 
NRG1 promotes motility and directed migration in cultured Schwann cells 
(Mahanthappa et al., 1996) 
 
Schwann cell precursor differentiation 
  Apart from survival regulation, another important aspect of the close axonal-
glial relationships in embryonic nerves is likely to be the control of the differentiation 
of SCPs into immature Schwann cells by axonal signals. A number of signals that are 
known or likely to be associated with axons, including NRG1, endothelins and the 
Notch signalling pathways, can regulate the phenotypic changes associated with this 
transition. Many of these changes can be faithfully reproduced in simple cell culture 
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model, in which the SCP-Schwann cell transition takes place approximately on 
schedule. For example, when E14 SCPs are cultured in medium containing NRG1 for 
4 days (E14+4), the resulting cells exhibit most of the essential phenotype of 
Schwann cells freshly dissociated from E18 nerves. Thus, the cultured E14+4 cells 
have developed autocrine survival mechanisms and have the characteristic antigenic 
profile and mitogenic responses of Schwann cells rather than SCPs (Dong et al., 
1995, 1999; Leimeroth et al., 2002). These experiments show that NRG1 as well as 
supporting the survival of SCPs is sufficient for their maturation to Schwann cells. In 
vitro FGF-2 can accelerate NRG1-mediated Schwann cell generation (Dong et al., 
1995), although this has not been demonstrated in vivo. Notch signalling also can 
accelerate the generation of immature Schwann cells from SCPs. SCPs express Notch 
receptors on their surface and enforced expression of NICD, the active portion of 
Notch receptor, results in an accelerated maturation of SCPs both in vivo and in vitro. 
Conversely, disruption of Notch signalling in SCPs results in a retardation of 
immature Schwann cell generation in vivo (A. Woodhoo, R. Mirsky and K.R. Jessen, 
unpublished). Thus, Notch signalling is a positive regulator of SCP maturation that 
has a role in timing Schwann cell generation.  
Another signal that could be involved in this transition is endothelin, acting 
through the endothelin B receptor. Both endothelin and its receptor are present in 
developing nerves (Brennan et al., 2000). Although exposure to endothelin promotes 
the survival of SCPs, their maturation to Schwann cells occurs very slowly. 
Furthermore, the maturation of the SCPs, in the presence of NRG1 and endothelin, 
occurs at a rate that is slower than that in NRG1 alone. These data argue for 
antagonistic roles of NRG1 and endothelin on SCP maturation; whereas NRG1 
promotes Schwann cell generation in vitro, endothelin retards it. In the spotting lethal 
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rat, in which the endothelin B receptors are non-functional, Schwann cells are 
generated ahead of schedule (Brennan et al., 2000), providing further evidence for the 
negative role of endothelin in SCP maturation. The only transcription factor shown to 
have a role in the SCP/SC transition is AP2α, which delays Schwann cell generation 
when it is over-expressed in SCPs in vitro (Stewart et al., 2001). Expression of AP2α 
is sharply down-regulated, both in rats and in mice, at the transition point, suggesting 
its importance in vivo in the regulation of Schwann cell generation (Stewart et al., 
2001). 
Recently, using Cre recombinase-mediated fate mapping, it was shown that 
the small population of endoneurial fibroblasts present in P11 mice sciatic nerves 
were derived from cells present in E12 embryonic nerves (Joseph et al., 2004). The 
large majority of the cells in the E12 nerves are SCPs, i.e. cells that unambiguously 
show a glial phenotype, including co-expression of BFABP, P0 and Dhh, and a tight 
association with neurons/axons (reviewed in Jessen and Mirsky, 2005). The 
generation of fibroblastic cells from SCPs, therefore, shows that cells with a glial 
phenotype not only possess an unexpectedly broad developmental potential upon 
isolation, as discussed above (Hagedorn et al., 1999; Wong et al., 2006), but are also 
multifated in vivo. 
Given that SCPs give rise to both Schwann cells and fibroblasts, it is of 
considerable interest to find which cues enable them to choose between these two cell 
fates. One interesting possibility is the changes in their immediate environment 
brought about by the re-shaping of the cytoarchitecture of the developing nerves. As 
mentioned above, fibroblasts appear at about the same time as the tightly packed 
structure of the nerve changes to a loose one, with deposition of an extracellular 
matrix. This could result in some of the glial cells in these nerves losing contact with 
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axons and lying naked in the extracellular spaces. If this was the case, it is plausible 
that the cells that retain contact with axons would proceed to give rise to Schwann 
cells, which is in agreement with all the observations that show the requirement for 
axonal signals in Schwann cell generation (see above). In addition, it is likely that 
these axonal signals would suppress the differentiation of these SCPs into endoneurial 
fibroblasts because two of these signals, NRG1 and Notch, have already been shown 
to suppress the generation of fibroblast-like cells in the neural crest lineage (Morrison 
et al., 2000; Shah et al., 1994). Those SCPs that are not associated with axons would 
not be exposed to these signals and their differentiation to fibroblasts would not be 
inhibited. In addition, exposure to potential pro-fibroblast factors in the extracellular 
matrix could also be important.      
   
Immature Schwann cells 
In E17/E18 rat nerves (E15/16 in mice), groups of axons are clustered together 
and communally enveloped by immature Schwann cells, forming ‘axon – Schwann 
cell’ families (Webster and Favilla, 1984). Large diameter axons then become 
selectively ensheathed by immature Schwann cells and form 1:1 relationships with 
them, a process known as radial sorting. This is a prerequisite for myelination, which 
begins at around birth in rodents. During this stage of nerve development, the axon 
and Schwann cell numbers need to be matched. Since developmental neuronal death 
is largely over at these late embryonic stages (Davies, 1996), this is achieved by 
regulating Schwann cell survival and proliferation.   
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Control of immature Schwann cell numbers 
Cell division is a characteristic feature of the SCP and immature Schwann cell 
stages. In rats, whilst proliferation is high in Schwann cell precursors, the maximum 
rate of division occurs in immature Schwann cells at E18/19 (Stewart et al., 1993). 
Similarly, in mice, proliferation is high at the Schwann cell precursor stage (E13), but 
significantly increases and reaches a peak at the immature Schwann cell stage (E15 
onwards) (Yu et al., 2005). Schwann cell proliferation has been shown to be axonally-
induced in in vitro studies, where direct contact with neurites and neurite fractions 
were shown to induce cell division in Schwann cells (Salzer et al., 1980). Transection 
of sciatic nerves in newborn rats results in a reduction in Schwann cell proliferation as 
they lose contact with the axons (Komiyama and Suzuki, 1992), consistent with the 
idea that axons provide a mitogenic signal to developing Schwann cells. One of the 
axonal mitogenic factors has been shown to be NRG1, in in vitro Schwann cell-DRG 
co-culture studies (Morrissey et al., 1995), although there appears to be no direct in 
vivo evidence for this as yet.  
Another mitogen that has been shown to be important in controlling Schwann 
cell division is Transforming Growth Factor-β  (TGF-β) both in vitro and in vivo. 
TGF-β can induce proliferation in Schwann cell cultures (Einheber et al., 1995; 
Guenard et al., 1995; Ridley et al., 1989). More importantly, in mice, in which the 
type II TGF-β receptor has been genetically inactivated in Schwann cells, 
proliferation as measured by in vivo BrdU labelling and presence of the mitosis 
marker phospho-histone 3 is reduced (D’Antonio M et al., 2006). In contrast, 
functional overexpression of the protooncogene Ski, an inhibitor of TGF-β signalling, 
prevents TGF-β mediated proliferation and cell cycle re-entry of growth-arrested 
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Schwann cells (Atanasoski et al., 2004). Ski also promotes myelin formation 
independently of its role in regulating Schwann cell proliferation, suggesting that Ski 
provides a link between Schwann cell growth and differentiation. Finally, in vivo 
proliferation assays have shown that laminins, which are major constituents of the 
basal lamina surrounding Schwann cells, also promote Schwann cell proliferation. 
Deletion of laminins 2 and 8 (which are the major laminins present in the basal 
lamina) leads to a severe reduction in Schwann cell mitosis (Yang et al., 2005). 
Genetic ablation of the laminin γ chain, which is the common sub-unit of both 
laminin 2 and 8, also results in reduced proliferation in Schwann cells (Yu et al., 
2005).  
The survival of immature Schwann cells in late embryonic and perinatal 
nerves is probably regulated by an interplay between survival and death signals. 
Apoptosis, in the same way as proliferation, is a feature of immature Schwann cells 
during their normal development, as revealed by TUNEL labelling of dying cells in 
nerve sections (Feltri et al., 2002; Grinspan et al., 1996). Two major death signals in 
Schwann cells have been identified in vivo and in vitro so far. Nerve Growth Factor 
(NGF), acting through its receptor p75NTR, induces cell death in cultured Schwann 
cells, and Schwann cells isolated from p75NTR knockout mice survive better than cells 
from normal mice when subjected to serum or growth factor deprivation (Soilu-
Hanninen et al., 1999; Syroid et al., 2000). Furthermore, Schwann cell apoptosis is 
markedly reduced in the p75NTR knockout mice following neonatal sciatic nerve 
transection, although the levels of apoptotic death in control and mutant mice during 
normal development are similar (Syroid et al., 2000). These results suggest that 
p75NTR-mediated Schwann cell death is not important for natural cell death seen in 
vivo during early development (Grinspan et al., 1996), although it might be important 
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during nerve injury. The other death signal identified in Schwann cells during early 
development is TGF-β Cultured Schwann cells die by apoptotic cell death with 
exposure to TGF-β (Parkinson et al., 2001, Skoff et al., 1998) and in mice, in which 
type II TGF-β receptor has been genetically inactivated, there are reduced levels of 
cell death in E18 sciatic nerves, when compared to normal mice (D’Antonio et al., 
2006).  
 A number of signals that promote survival of Schwann cell have been 
identified. These include axon-associated factors such as NRG1, autocrine signals, 
and basal lamina components. Transection of sciatic nerves, which causes axonal 
degeneration, leads to an increase in Schwann cell apoptosis suggesting a role for an 
axonal factor in regulating survival. This axonal factor appears to be NRG1, since 
exogenously applied NRG1 is able to prevent the death of some of the Schwann cells 
(Grinspan et al., 1996). Schwann cells also possess autocrine survival mechanisms, at 
least in vitro, that allow them to regulate their survival. However, at present there is 
no in vivo evidence for these mechanisms (see above). Laminins, on the other hand, 
have been shown to have an essential role in promoting Schwann cell survival in vivo. 
Genetic ablation of the laminin γ subunit results in a significant increase in Schwann 
cell apoptosis in E17 sciatic nerves, in addition to reduced proliferation mentioned 
above (Yu et al., 2005). The increase in Schwann cell apoptosis in these mutant mice 
has been shown to result from a reduction in phosphatidyl-inosital-3 (PI3) kinase 
activity. This pathway is also involved in mediating lysophosphatidic acid (LPA)-
induced Schwann cell survival following serum withdrawal (Weiner and Chun, 1999; 
Weiner et al., 2001). In sum, many factors influencing Schwann cell numbers by 
regulating cell survival also affect cell proliferation, indicating that these two 
processes are tightly linked during Schwann cell development. 
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Radial sorting. 
Immature Schwann cells undergo profound phenotypic changes as they 
differentiate into myelinating and non-myelinating Schwann cells. Before birth, 
Schwann cells send cytoplasmic processes into groups of axons, progressively 
defasciculating them. Large diameter axons (>1 um in diameter) undergo the process 
of radial sorting and establish a 1:1 relationship with individual Schwann cells, in 
preparation for myelination. Groups of smaller diameter axons, destined to remain 
unmyelinated, are surrounded by non-myelinating Schwann cells, which 
accommodate them in troughs aplong the surface. Some of the molecular mechanisms 
that underlie radial sorting have only recently been established. By large, radial 
sorting is dependent on interactions between laminins present in the basal lamina 
surrounding Schwann cells and their receptors, β1 integrins present in Schwann cells. 
Recently, the Rho family GTPase Rac1 has been identified as the downstream 
molecule involved in this process (Benninger et al., 2007; Nodari et al., 2007) 
(discussed in detail in Feltri and Suter, this issue). 
 
Myelination. 
  The establishment of myelin sheaths around large diameter axons provides 
rapid saltatory conduction of nerve impulses along them. Small diameter axons, 
however, do not require such myelin sheaths since the speed of impulse transmission 
in those axons is probably not improved, as suggested (reviewed in Sherman and 
Brophy, 2005). The molecular phenotype of both immature and non-myelinating 
Schwann cells are relatively similar, at least in their morphology and expression of 
their antigenic markers, with the exception of GalC and αβ and α β integrins, which 
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are expressed only in non-myelinating Schwann cells (Jessen and Mirsky, 2005; 
Previtali et al., 2003; Stewart et al., 1997). Thus, it is expected that there are few 
molecular changes that accompany the differentiation of immature Schwann cells into 
non-myelinating Schwann cells, although this has not been extensively studied.  
Generation of myelinating Schwann cells, on the other hand, proceeds with 
much more profound molecular changes, as most of the antigens associated with 
immature Schwann cells are downregulated and there is an upregulation of a number 
of genes associated with control of myelination and formation of the myelin sheath 
(reviewed in Jessen and Mirsky, 2005). Laminins present in the basal lamina and their 
receptors, integrins, as well as pro-myelination factors, including Oct-6, Krox 20, Nab 
1/2, Brn-2 and Sox10, have integral functions in myelination (discussed in detail in 
Svaren and Meijer, this issue). NRG1, in addition to its roles in early Schwann cell 
development, also has critical roles during myelination and control of myelin 
thickness (reviewed in Britsch, 2007; Nave and Salzer, 2006; Birchmeier and Nave, 
this issue). There is also increasing evidence that Schwann cells contain signalling 
pathways that, when activated, will inhibit or reverse myelination. These negative 
regulators of myelination include the c-Jun amino (N)-terminal kinase (JNK) and 
Notch signalling pathways (Jessen et al, this issue). 
 
CONCLUSION 
Over the recent years, much has been learnt about Schwann cell development, 
from the initial process of gliogenesis to myelination. Each developmental stage in the 
Schwann cell lineage can nowadays be unambiguously identified by their unique sets 
of molecular markers, signalling responses and tissue relationships. Also, a number of 
signalling pathways have been identified that have fundamental roles during 
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differentiation and in the maintenance of these stages. Amongst the most important 
identified so far are the NRG and Notch signalling pathways, which have roles in 
almost all the transitional stages in the Schwann cell lineage. The microenvironment, 
in which glial differentiation takes place, is most likely to be also very important in 
differentiation and maintenance of these cells, and one of the important challenges in 
Schwann cell development is identifying how the constantly changing architecture of 
embryonic nerves influence these processes. In addition, the key molecular events in 
gliogenesis and myelination still need to be established. 
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FIGURE LEGENDS 
 
Figure 1: Transitional stages in embryonic Schwann cell development can be 
defined by (A) their molecular profile, (B) signaling responses and (C) gene 
expression.  
(A) The study of the Schwann cell lineage has necessitated the development of 
molecular markers to distinguish the different stages. Nowadays, a rather complete set 
of antigens is available to distinguish their stages which are classified into 5 major 
groups: antigens present in the whole of the early Schwann cell lineage (yellow box), 
antigens present only in crest cells and SCPs (blue box), antigens present only in 
SCPs (green box), antigens present in SCPs and Schwann cells (orange box) and 
antigens present only in Schwann cells (red box).  
(B) Survival mechanisms also differ remarkably between the three cell types. 
In vitro, NRG1-mediated survival in neural crest cells is dependent on presence of 
extracellular matrix (ECM), whilst ECM is not required for NRG-1-mediated survival 
in SCPs and immature Schwann cells. This is likely to be relevant to their tissue 
interactions in vivo since neural crest cells are associated with ECM, whereas SCPs 
and immature Schwann cells are associated with axons. A number of growth factors 
combinations, including PDGF plus NT3 and IGF, ET plus IGF, and FGF plus IGF 
promotes SCP and immature Schwann cell survival but not of neural crest cells. 
Finally, autocrine survival mechanisms are present only in immature Schwann cells. 
(C) Gene expression profiling shows extensive changes in gene expression in 
the different stages. The genes regulated are grouped into functional categories and 
are indicated in red for genes in these groups mainly upregulated or in blue if mainly 
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downregulated. Details of individual genes regulated in the lineage are given in 
Buchstaller et al., 2004. See text for further references. 
 
Figure 2. Neural crest cells give rise to various types of peripheral glia 
distinguished by their localization, specific marker expression, factor 
responsiveness, and function. 
Schwann cells along peripheral nerves, satellite cells in peripheral ganglia, and 
boundary cap cell-derived Schwann cells in nerve roots represent distinct peripheral 
glia subtypes generated from the neural crest. Arrows do not necessarily reflect actual 
lineage relationships. However, cell lineage tracking experiments, genome wide 
expression analysis, and distinct growth factor responsiveness point to the segregation 
of the Schwann cell lineage from other lineages already at early stages of neural crest 
development and, hence, to specific mechanisms of specification. See text for 
references. 
 
 
